 Shares of Conmed NYSE:CNMD moved higher by 4.42 in after-market trading after the company reported Q2 results.Quarterly Results Earnings per share decreased 112.50 over the past year to 0.07, which beat the estimate of 0.95.Revenue of 157,785,000 declined by 33.78 year over year, which beat the estimate of 126,590,000.Looking Ahead Earnings guidance hasnt been issued by the company for now.Conmed hasnt issued any revenue guidance for the time being.Details Of The Call Date: Jul 29, 2020View more earnings on CNMDTime: 04:30 PMET Webcast URL: 52-week high: 116.8152-week low: 37.66Price action over last quarter: Up 11.96Company Description Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgery. The firm currently reports through two reporting units, orthopedic surgery 52 of 2018 sales and general surgery 48. From a geographic perspective the firm is U.S. centric, with domestic sales accounting for 52 of revenue, EMEA accounting for 19, APAC at 17, and the non-U.S. Americas region driving the remaining 12.See more from Benzinga Earnings Outlook For ConmedC 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. 